Keyphrases
Xenograft
100%
Human Cell Lines
100%
Response to Chemotherapy
100%
Esophageal Cancer
100%
Prognostic Biomarker
100%
Plasma Proteomics
100%
Proteomic Profiling
100%
Esophageal Adenocarcinoma
66%
Chemotherapy
50%
Clinical Samples
33%
Plasma Proteins
33%
Prediction Model
16%
Cisplatin
16%
Protein Markers
16%
Response Marker
16%
Therapeutic Response
16%
Treatment Group
16%
Apolipoprotein A-I (ApoA-I)
16%
Adenocarcinoma
16%
Cancer Patients
16%
Plasma Samples
16%
Serum Amyloid A
16%
Surface-enhanced Laser Desorption/ionization Time-of-flight
16%
OE19
16%
Epirubicin
16%
Purified Fractions
16%
Paired Samples
16%
Time-of-flight Mass Spectroscopy
16%
Proteomic Markers
16%
Targeted Treatment
16%
Neoadjuvant Chemotherapy
16%
Immune-deficient Mice
16%
5-fluorouracil (5-FU)
16%
Transthyretin Amyloidosis
16%
Class Prediction
16%
Tryptic Digest
16%
Xenograft Model
16%
Test Efficiency
16%
Mass Spectroscopy
16%
Marker Panel
16%
Medicine and Dentistry
Xenograft
100%
Cell Line
100%
Cancer Biomarkers
100%
Proteomics
100%
Chemotherapy
100%
Esophageal Adenocarcinoma
57%
Blood Proteins
28%
Malignant Neoplasm
14%
Cisplatin
14%
Treatment Response
14%
Analysis of Variance
14%
Adenocarcinoma
14%
Mass Spectrum
14%
Esophageal Cancer
14%
Transthyretin
14%
Surface Enhanced Laser Desorption Ionization Time of Flight Mass Spectrometry
14%
Epirubicin
14%
Apolipoprotein A
14%
Serum Amyloid A
14%
SCID Mouse
14%
Neoadjuvant Chemotherapy
14%
Fluorouracil
14%
Biochemistry, Genetics and Molecular Biology
Proteomics
100%
Blood Plasma
100%
Blood Proteins
100%
Cisplatin
50%
Time-of-Flight Mass Spectrometry
50%
Fluorouracil
50%
Transthyretin
50%
Epirubicin
50%
Surface-Enhanced Laser Desorption/Ionization
50%
SCID Mouse
50%
Serum Amyloid A
50%
Apolipoprotein
50%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Chemotherapy
100%
Esophagus Cancer
100%
Esophageal Adenocarcinoma
66%
Plasma Protein
33%
Malignant Neoplasm
16%
Cisplatin
16%
Adenocarcinoma
16%
Fluorouracil
16%
Epirubicin
16%
SCID Mouse
16%
Serum Amyloid A
16%
Transthyretin
16%
Surface-Enhanced Laser Desorption/Ionization
16%
Apolipoprotein A
16%
Immunology and Microbiology
Xenograft
100%
Human Cell
100%
Cell Line
100%
Blood Plasma
100%
SCID Mouse
14%
Time-of-Flight Mass Spectrometry
14%
Desorption
14%
Serum Amyloid A
14%